TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
119 hedge funds and large institutions have $572M invested in TCR2 Therapeutics Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
76% less call options, than puts
Call options by funds: $1.46M | Put options by funds: $6.06M
Holders
119
Holding in Top 10
3
Calls
$1.46M
Puts
$6.06M
Top Buyers
| 1 | +$8.87M | |
| 2 | +$6.54M | |
| 3 | +$2.55M | |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$2.16M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.56M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$11.1M | |
| 3 | -$6.9M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$6.15M |
| 5 |
O
OrbiMed
New York
|
-$5.5M |